Clinical Study

Salivary Acetylcholinesterase Activity Is Increased in Parkinson’s Disease: A Potential Marker of Parasympathetic Dysfunction

Table 1

Clinical and demographic characteristics of patients and controls.

Controls
()
PD patients
()
value

Age62.7 ± 9.463.7 ± 9.10.6
Sex (M/F)27/2216/140.88
MMSE28.9 ± 1.128.6 ± 1.50.5
UPDRS IIIN/A27 ± 12.8N/A
H&Y stageN/A1.9 ± 0.5N/A
Duration since PD diagnosis (years)N/A4.8 ± 3.3N/A

All values are mean ± SD.